Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical muri ...
W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...
CROSS-SPECIES BBB-PENETRANT IV-DELIVERED AAV GENE THERAPY PROVIDES BROAD AND ROBUST CNS TAU LOWERING IN TAUOPATHY MOUSE AND ...
The brain disease model of addiction has dominated public and scientific discourse on addiction (termed substance use disorder [SUD] in the DSM-5) over the past 3 decades. The model framed addiction ...
Columbia scientists mapped brain mitochondria for the first time, revealing how energy shapes memory, mood, and mental health ...
Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, researchers report ‘seeding’ this accumulation through fragments of the culprit ...
Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, ...
Send a loud and clear message to your lawmakers NOW and join AARP's fight to protect your Social Security! Help Register ...
The human brain runs on a tight energy budget. Despite making up only 2% of our body weight, it devours around 20% of our ...
New research from the University of Chicago challenges long-held beliefs about how synaptic plasticity contributes to memory ...
UNLV research team says high blood sugar levels appear to weaken function in key part of brain, mimicking Alzheimer’s.